DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC

Clinical trial NCT07207824 · RECRUITING

Trial details

NCT number: NCT07207824
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder (Urothelial, Transitional Cell) Cancer NMIBC

Start date: 2025-12-01
Primary completion: 2030-06-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.